✦ LIBER ✦

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ Scribed by C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. Yip; F. Lofts; C. Gallagher; H. Thomas; P.G. Harper

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin followed b

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Weekly paclitaxel and carboplatin follow

✍ J.A. Arranz Arija; R. Gonzalez-Beca; A. Velasco; M.M. Perez; P. Borrega; M. Bola 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 363 KB

A phase II feasibility study of carbopla

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Phase I Trial of Carboplatin, Paclitaxel

✍ Nadine Tung; Ross Berkowitz; Ursula Matulonis; Marc Quartulli; Michael Seiden; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A phase II study of sequential docetaxel

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB

First-line therapy for ovarian cancer wi

✍ Roshan Agarwal; Charlie Gourley; Timothy J. Perren; Nicholas Reed; David E. Park 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB